CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Sulpiride

舒必利 杂质对照品Sulpiride Impurities

EP39 个杂质条目39 impurity entries

本页汇总 舒必利 的 39 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 39 impurity reference standards of Sulpiride with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 舒必利(Sulpiride)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesSimultaneous determination of sulpiride and its alkaline degradation product by second derivative synchronous fluorescence spectroscopy
    Talanta · 2009 · Abdelal A et al.  ·  PMID 19836568  ·  DOI
  2. 杂质研究Impurity studiesQuantitative analysis of sulpiride and impurities of 2-aminomethyl-1-ethylpyrrolidine and methyl-5-sulphamoyl-2-methoxybenzoate in pharmaceuticals by high-performance thin-layer chromatography and scanning densitometry
    Journal of AOAC International · 1999 · Agbaba D et al.  ·  PMID 10490314
  3. 杂质研究Impurity studiesDevelopment and validation of stability indicating HPLC and HPTLC methods for determination of sulpiride and mebeverine hydrochloride in combination
    European journal of medicinal chemistry · 2010 · Naguib IA, Abdelkawy M  ·  PMID 20538381  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisIsolation, identification, and synthesis of the major sulpiride metabolite in primates
    Journal of pharmaceutical sciences · 1982 · Brennan JJ et al.  ·  PMID 7175707  ·  DOI
  • 合成方法Synthesis[Attempt at a synthesis of the neurophysiological data concerning sulpiride and sultopride]
    Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille · 1979 · Gekiere F et al.  ·  PMID 553216

舒必利 —— 原料药与杂质对照品Sulpiride — drug substance & impurities

共 40 个条目(含原料药本体)40 items incl. the drug substance
Sulpiride structure
EP原料药 APIAPI
舒必利Sulpiride
Sulpiride
CAS No.15676-16-1
Chemical FormulaC15H23N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 2(Sulpiride EP Impurity B) structure
EPB
舒必利杂质2(舒必利EP杂质B)Sulpiride Impurity 2(Sulpiride EP Impurity B)
Sulpiride Impurity 2(Sulpiride EP Impurity B)
CAS No.33045-52-2
Chemical FormulaC9H11NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 3(Sulpiride EP Impurity C) structure
EPC
舒必利杂质3(舒必利EP杂质C)Sulpiride Impurity 3(Sulpiride EP Impurity C)
Sulpiride Impurity 3(Sulpiride EP Impurity C)
CAS No.33045-53-3
Chemical FormulaC10H13NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 4(Sulpiride EP Impurity D) structure
EPD
舒必利杂质4(舒必利EP杂质D)Sulpiride Impurity 4(Sulpiride EP Impurity D)
Sulpiride Impurity 4(Sulpiride EP Impurity D)
CAS No.22117-85-7
Chemical FormulaC8H9NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 5(Sulpiride EP Impurity E) structure
EPE
舒必利杂质5(舒必利EP杂质E)Sulpiride Impurity 5(Sulpiride EP Impurity E)
Sulpiride Impurity 5(Sulpiride EP Impurity E)
CAS No.52395-25-2
Chemical FormulaC8H10N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 6(Sulpiride EP Impurity F) structure
EPF
舒必利杂质6(舒必利EP杂质F)Sulpiride Impurity 6(Sulpiride EP Impurity F)
Sulpiride Impurity 6(Sulpiride EP Impurity F)
CAS No.2214214-03-4
Chemical FormulaC15H23N3O5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 7(Sulpiride EP Impurity G) structure
EPG
舒必利杂质7(舒必利EP杂质G)Sulpiride Impurity 7(Sulpiride EP Impurity G)
Sulpiride Impurity 7(Sulpiride EP Impurity G)
CAS No.67381-52-6
Chemical FormulaC14H21N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 8 structure
8
舒必利杂质8Sulpiride Impurity 8
Sulpiride Impurity 8
CAS No.950226-51-4
Chemical FormulaC14H12ClNO5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 9 structure
9
舒必利杂质9Sulpiride Impurity 9
Sulpiride Impurity 9
CAS No.950253-88-0
Chemical FormulaC17H17NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 10 structure
10
舒必利杂质10Sulpiride Impurity 10
Sulpiride Impurity 10
CAS No.126884-27-3
Chemical FormulaC13H12N2O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 11 structure
11
舒必利杂质11Sulpiride Impurity 11
Sulpiride Impurity 11
CAS No.823823-43-4
Chemical FormulaC15H13NO7S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 12 structure
12
舒必利杂质12Sulpiride Impurity 12
Sulpiride Impurity 12
CAS No.701253-31-8
Chemical FormulaC14H9ClF3NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 13 structure
13
舒必利杂质13Sulpiride Impurity 13
Sulpiride Impurity 13
CAS No.62547-10-8
Chemical FormulaC13H10ClNO5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 14 structure
14
舒必利杂质14Sulpiride Impurity 14
Sulpiride Impurity 14
CAS No.518053-71-9
Chemical FormulaC13H10ClNO5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 15 structure
15
舒必利杂质15Sulpiride Impurity 15
Sulpiride Impurity 15
CAS No.433702-39-7
Chemical FormulaC15H13NO7S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 16 structure
16
舒必利杂质16Sulpiride Impurity 16
Sulpiride Impurity 16
CAS No.109029-89-2
Chemical FormulaC15H12ClNO5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 17 structure
17
舒必利杂质17Sulpiride Impurity 17
Sulpiride Impurity 17
CAS No.351898-80-1
Chemical FormulaC14H11Cl2NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 18 structure
18
舒必利杂质18Sulpiride Impurity 18
Sulpiride Impurity 18
CAS No.326882-45-5
Chemical FormulaC15H13NO7S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 19 structure
19
舒必利杂质19Sulpiride Impurity 19
Sulpiride Impurity 19
CAS No.326882-44-4
Chemical FormulaC15H13NO7S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 20 structure
20
舒必利杂质20Sulpiride Impurity 20
Sulpiride Impurity 20
CAS No.423728-81-8
Chemical FormulaC20H15ClN2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 21 structure
21
舒必利杂质21Sulpiride Impurity 21
Sulpiride Impurity 21
CAS No.313225-61-5
Chemical FormulaC13H9ClFNO4S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 22 structure
22
舒必利杂质22Sulpiride Impurity 22
Sulpiride Impurity 22
CAS No.325724-62-7
Chemical FormulaC13H9Cl2NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 23 structure
23
舒必利杂质23Sulpiride Impurity 23
Sulpiride Impurity 23
CAS No.328110-84-5
Chemical FormulaC14H11NO6S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 24 structure
24
舒必利杂质24Sulpiride Impurity 24
Sulpiride Impurity 24
CAS No.312604-16-3
Chemical FormulaC20H15BrN2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 25 structure
25
舒必利杂质25Sulpiride Impurity 25
Sulpiride Impurity 25
CAS No.313259-41-5
Chemical FormulaC14H12ClNO4S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 26 structure
26
舒必利杂质26Sulpiride Impurity 26
Sulpiride Impurity 26
CAS No.68189-34-4
Chemical FormulaC13H10ClNO4S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 27 structure
27
舒必利杂质27Sulpiride Impurity 27
Sulpiride Impurity 27
CAS No.62547-13-1
Chemical FormulaC13H10N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 28 structure
28
舒必利杂质28Sulpiride Impurity 28
Sulpiride Impurity 28
CAS No.413583-24-1
Chemical FormulaC14H10ClNO6S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 29 structure
29
舒必利杂质29Sulpiride Impurity 29
Sulpiride Impurity 29
CAS No.554426-69-6
Chemical FormulaC15H14N2O6S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 30 structure
30
舒必利杂质30Sulpiride Impurity 30
Sulpiride Impurity 30
CAS No.670266-31-6
Chemical FormulaC16H17NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 31 structure
31
舒必利杂质31Sulpiride Impurity 31
Sulpiride Impurity 31
CAS No.23672-07-3
Chemical FormulaC15H23N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 32 structure
32
舒必利杂质32Sulpiride Impurity 32
Sulpiride Impurity 32
CAS No.62105-07-1
Chemical FormulaC15H23N3O5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 33 structure
33
舒必利杂质33Sulpiride Impurity 33
Sulpiride Impurity 33
CAS No.3337-71-1
Chemical FormulaC8H10N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 35 structure
35
舒必利杂质35Sulpiride Impurity 35
Sulpiride Impurity 35
CAS No.191471-91-7
Chemical FormulaC9H9ClO5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 36 structure
36
舒必利杂质36Sulpiride Impurity 36
Sulpiride Impurity 36
CAS No.77718-16-2
Chemical FormulaC8H8ClNO4S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 38 structure
38
舒必利杂质38Sulpiride Impurity 38
Sulpiride Impurity 38
CAS No.57734-56-2
Chemical FormulaC13H19N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 38 Hydrochloride structure
38
舒必利杂质38 盐酸盐Sulpiride Impurity 38 Hydrochloride
Sulpiride Impurity 38 Hydrochloride
CAS No.65612-68-2
Chemical FormulaC13H19N3O4S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 40 (D-Sulpiride) structure
40
舒必利杂质40 (D-舒必利)Sulpiride Impurity 40 (D-Sulpiride)
Sulpiride Impurity 40 (D-Sulpiride)
CAS No.23756-79-8
Chemical FormulaC15H23N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 43 structure
43
舒必利杂质43Sulpiride Impurity 43
Sulpiride Impurity 43
CAS No.2201038-36-8
Chemical FormulaC15H23N3O5S
Purity>95%询价On request
10mg25mg50mg100mg
Sulpiride Impurity 31-d3 structure
31-D3
舒必利杂质31-d3Sulpiride Impurity 31-d3
Sulpiride Impurity 31-d3
CAS No.124020-27-5
Chemical FormulaC15H20D3N3O4S
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

舒必利 —— 研究文献与合成路线Sulpiride — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 舒必利 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Sulpiride. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development and validation of stability indicating HPLC and HPTLC methods for determination of sulpiride and mebeverine hydrochloride in combination
    Naguib IA, Abdelkawy M · European journal of medicinal chemistry · 2010 · 被引 12cited 12
  2. Support vector regression and artificial neural network models for stability indicating analysis of mebeverine hydrochloride and sulpiride mixtures in pharmaceutical preparation: a comparative study
    Naguib IA, Darwish HW · Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2012 · 被引 5cited 5
  3. Simultaneous determination of sulpiride and its alkaline degradation product by second derivative synchronous fluorescence spectroscopy
    Abdelal A, El-Enany N, Belal F · Talanta · 2009 · 被引 17cited 17
  4. Quantitative analysis of sulpiride and impurities of 2-aminomethyl-1-ethylpyrrolidine and methyl-5-sulphamoyl-2-methoxybenzoate in pharmaceuticals by high-performance thin-layer chromatography and scanning densitometry
    Agbaba D, Miljkovic T, Marinkovic V, et al. · Journal of AOAC International · 1999 · 被引 1cited 1
  5. Determination of sulpiride in pharmaceutical preparations and biological fluids using a Cr (III) enhanced chemiluminescence method
    Khan MN, Jan MR, Shah J, et al. · Luminescence : the journal of biological and chemical luminescence · 2013 · 被引 1cited 1

合成与制备工艺专利Synthesis & process patents

  1. Galenic of sulpiride, process for its preparation and medicament comprising it
    LARUELLE Claude · 公开号 EP0107557EP0107557 · 1984
  2. Raceme sulpiride resolution process
    MAURI FRANCESCO · 公开号 EP0053584EP0053584 · 1982

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

舒必利 杂质谱研究要点Sulpiride — impurity profiling notes

下面这些是拿到 舒必利 的 40 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 40 impurity entries for Sulpiride, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances